Immunobiology and Cancer Program, Oklahoma Medical Research Foundation, 825 NE13th Street, Oklahoma City, OK 73104, USA.
J Immunol Methods. 2010 Jul 31;359(1-2):47-55. doi: 10.1016/j.jim.2010.06.002. Epub 2010 Jun 9.
Progress has been slow in defining molecular requirements for human B lymphopoiesis in part because of differences from experimental animals and also because of the lack of culture conditions that efficiently support the process. We recently found that human CD10+ lymphocytes were produced when CD34+ hematopoietic stem and progenitor cells were cultured in contact with human mesenchymal stem cells (hMSC). Further investigation revealed that it occurred even when progenitors were separated from hMSC by membrane filters. Experiments with neutralizing antibodies suggested that important heat labile factors produced by hMSC are unlikely to be IL-7, TSLP, CXCL12 or hemokinin-1. Further manipulation of culture conditions revealed that optimal lymphopoiesis required careful selection of fetal calf serum lots, maintenance of high cell densities, as well as recombinant cytokines (SCF, FL and G-CSF). G-CSF was particularly important when adult bone marrow rather than umbilical cord blood derived CD34+ cells were used to initiate the cultures. These improved methods should facilitate identification of molecules that can be used to speed regeneration of the humoral immune system following chemotherapy and might suggest ways to inhibit growth of B lineage malignancies.
在定义人类 B 淋巴发生的分子要求方面进展缓慢,部分原因是与实验动物的差异,也因为缺乏有效支持该过程的培养条件。我们最近发现,当 CD34+造血干祖细胞与人类间充质干细胞(hMSC)接触培养时,会产生人类 CD10+淋巴细胞。进一步的研究表明,即使祖细胞通过膜过滤器与 hMSC 分离,也会发生这种情况。用中和抗体进行的实验表明,hMSC 产生的重要热不稳定因子不太可能是 IL-7、TSLP、CXCL12 或 hemokinin-1。进一步的培养条件操作表明,最佳的淋巴发生需要仔细选择胎牛血清批次、维持高细胞密度以及重组细胞因子(SCF、FL 和 G-CSF)。当使用成人骨髓而不是脐带血来源的 CD34+细胞来启动培养时,G-CSF 特别重要。这些改进的方法应该有助于鉴定可用于加速化疗后体液免疫系统再生的分子,并可能提示抑制 B 谱系恶性肿瘤生长的方法。